vestarВестник аритмологииJournal of Arrhythmology1561-86412658-7327НАО «Инкарт»vestar-369Research ArticleОБЗОРЫ ЛИТЕРАТУРЫ И МЕТА-АНАЛИЗЫREVIEWСИНДРОМ УДЛИНЁННОГО ИНТЕРВАЛА QT И ПРОБЛЕМЫ БЕЗОПАСНОСТИ ПСИХОФАРМАКОТЕРАПИИLONG QT INTERVAL SYNDROME AND PROBLEMS OF SAFETY OF PSYCHOPHARMACOTHERAPYЛиманкинаИ. Н.LimankinaI. N.noemail@neicon.ruСанкт-Петербургская психиатрическая больница №1 им. П.П.КащенкоRussian Federation20082209202052526671Copyright © Лиманкина И.Н., 20202020Лиманкина И.Н.Limankina I.N.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://vestar.elpub.ru/jour/article/view/369

Рассматриваются особенности проявления приобретенного синдрома удлиненного интервала QT, развивающегося на фоне применения психофармакотерапевтических препаратов.

The peculiar features are considered of acquired long QT interval syndrome developed at the background of psychopharmacological medical treatment.

синдром удлиненного интервала QTжизнеугрожающие желудочковые аритмиипсихофармакотерапевтические препаратыантидепрессантыlong QT interval syndromelife threatening ventricular arrhythmiaspsychopharmacological medicationsantidepressantsReferencesBuckley N, Sanders P. Cardiovascular adverse effects of antipsychotic drugs // Drug Safety 2000;23(3):215-228Buckley N, Sanders P. Cardiovascular adverse effects of antipsychotic drugs // Drug Safety 2000;23(3):215-228Brown S. Excess mortality of schizophrenia, a metaanalysis.// Br J Psychiatry 1997;171:502-508Brown S. Excess mortality of schizophrenia, a metaanalysis.// Br J Psychiatry 1997;171:502-508O’Brien P and Oyebode F. Psychotropic medication and the heart. // Advances in Psychiatric Treatment. 2003;9:414-423O’Brien P and Oyebode F. Psychotropic medication and the heart. // Advances in Psychiatric Treatment. 2003;9:414-423Abdelmawla N and Mitchel AJ. Sudden cardiac death and antipsychotics drugs. // Advances in Psychiatric Treatment 2006;12:35-44;100-109Abdelmawla N and Mitchel AJ. Sudden cardiac death and antipsychotics drugs. // Advances in Psychiatric Treatment 2006;12:35-44;100-109Herxheimer A, Healy D. Arrythmias and sudden death in patients taking antipsychotic drugs.// BMI 2002; 325:12531254Herxheimer A, Healy D. Arrythmias and sudden death in patients taking antipsychotic drugs.// BMI 2002; 325:12531254FDA issues public health advisory for antipsychotic drugs used for treatment of behavioral disorders in elderly patients (FDA talk Paper) Rochvill (MD): US Food and Drug Adminstration,2006FDA issues public health advisory for antipsychotic drugs used for treatment of behavioral disorders in elderly patients (FDA talk Paper) Rochvill (MD): US Food and Drug Adminstration,2006Schwartz PJ. The Long QT Syndrome. // Vol.7, Futura Publishing Company, Inc., Armonk, NY, 1997Schwartz PJ. The Long QT Syndrome. // Vol.7, Futura Publishing Company, Inc., Armonk, NY, 1997Schwartz PJ, Spazzolini C, Crotti L et al. The Jervell and Lange-Nielsen Sundrome: natural history, molecular basis and clinical outcome. // Circulation 2006;113:783-790Schwartz PJ, Spazzolini C, Crotti L et al. The Jervell and Lange-Nielsen Sundrome: natural history, molecular basis and clinical outcome. // Circulation 2006;113:783-790Бутаев Т.Д., Трешкур Т.В., Овечкина М.А. и др. Врождённый и приобретённый синдром удлинённог интервала QT (учебно-методическое пособие) Инкарт. Санкт-Петербург, 2002Бутаев Т.Д., Трешкур Т.В., Овечкина М.А. и др. Врождённый и приобретённый синдром удлинённог интервала QT (учебно-методическое пособие) Инкарт. Санкт-Петербург, 2002Camm AJ. Drug-Induced Long QT Syndrome // Vol.16, Futura Publishing Company, Inc., Armonk, NY, 2002Camm AJ. Drug-Induced Long QT Syndrome // Vol.16, Futura Publishing Company, Inc., Armonk, NY, 2002Van de Kraats GB, Slob J, Tenback DE. [Reduction of prolonged QTc-interval related risks with neuropharma-cological drugs. Recommendations for clinical practice].// Tijdschr Psychiatr 2007;49(1):43-47Van de Kraats GB, Slob J, Tenback DE. [Reduction of prolonged QTc-interval related risks with neuropharma-cological drugs. Recommendations for clinical practice].// Tijdschr Psychiatr 2007;49(1):43-47Glassman AH and Bigger JR. Antipsychotic drugs: prolonged QTc interval, torsade de pointes and sudden death.// American Journal of Psychiatry 2001;158:1774-1782Glassman AH and Bigger JR. Antipsychotic drugs: prolonged QTc interval, torsade de pointes and sudden death.// American Journal of Psychiatry 2001;158:1774-1782Vieweg WVR. Neu-generation antipsychotic drugs and QTc-interval prolongation.// Primary Care Companion J Clin Psychiatry 2003;5:205-215Vieweg WVR. Neu-generation antipsychotic drugs and QTc-interval prolongation.// Primary Care Companion J Clin Psychiatry 2003;5:205-215Mehtonen OP, Aranki K, Malkonen L et al. A survey of sudden death associated with the use of antipsychotics or antidepressant drugs: 49 cases in Finland.// Acta Psychiat-rica Scandinavica 1991;84:58-64Mehtonen OP, Aranki K, Malkonen L et al. A survey of sudden death associated with the use of antipsychotics or antidepressant drugs: 49 cases in Finland.// Acta Psychiat-rica Scandinavica 1991;84:58-64Ray WA, Meredith S, Thapa PB et al. Antipsychotics and the risk of sudden cardiac death.// Archives of General Psychiatry 2001;58:1161-1167Ray WA, Meredith S, Thapa PB et al. Antipsychotics and the risk of sudden cardiac death.// Archives of General Psychiatry 2001;58:1161-1167Straus SMJM, Bleumink GS, Dieleman JP et al. Antipsychotics and the risk of sudden cardiac death.// Archives of Internal Medicine 2004;164:1293-1297Straus SMJM, Bleumink GS, Dieleman JP et al. Antipsychotics and the risk of sudden cardiac death.// Archives of Internal Medicine 2004;164:1293-1297Trenton AJ, Currier GW, Zwemer FL. Fatalities associated with therapeutic use and overdose of atypical antipsychotics // CNS Drugs 2003;17:307-324Trenton AJ, Currier GW, Zwemer FL. Fatalities associated with therapeutic use and overdose of atypical antipsychotics // CNS Drugs 2003;17:307-324Victor W, Wood M. Tricyclic Antidepressants, QT Interval and Torsade de Pointes.// Psychosomatics 2004;45:371-377Victor W, Wood M. Tricyclic Antidepressants, QT Interval and Torsade de Pointes.// Psychosomatics 2004;45:371-377Thorstrand C. Clinical features in poisoning by tricyclic antidepressants with special reference to the ECG.// Acta Med Scan 1976;199:337-344Thorstrand C. Clinical features in poisoning by tricyclic antidepressants with special reference to the ECG.// Acta Med Scan 1976;199:337-344Wilens TE, Biederman J, Baldessarini RJ et al. Cardiovascular effects of therapeutic doses of tricyclic antidepressants in children and adolescents.// J Am Acad Child Adolesc Psychiatry 1995;35:1474-1480Wilens TE, Biederman J, Baldessarini RJ et al. Cardiovascular effects of therapeutic doses of tricyclic antidepressants in children and adolescents.// J Am Acad Child Adolesc Psychiatry 1995;35:1474-1480Riddle MA, Geller B, Ryan N. Another sudden death in a child treated with desipramine.// J Am Acad Child Ad-olesc Psychiatry 1993;32:792-797Riddle MA, Geller B, Ryan N. Another sudden death in a child treated with desipramine.// J Am Acad Child Ad-olesc Psychiatry 1993;32:792-797Varley CK, McClellan J. Case study: two additional sudden deaths with tricyclic antidepressants.// J Am Acad Child Adolesc Psychiatry 1997;36:390-394Varley CK, McClellan J. Case study: two additional sudden deaths with tricyclic antidepressants.// J Am Acad Child Adolesc Psychiatry 1997;36:390-394Oesterheld J. TCA cardiotoxicity: the latest.// J Am Acad Child Adolesc Psychiatry 1996;34:1460-1468Oesterheld J. TCA cardiotoxicity: the latest.// J Am Acad Child Adolesc Psychiatry 1996;34:1460-1468Swanson JR, Jones GR, Krasselt W et al. Death of two subjects due to imipramine and desipramine metabolite accumulation during chronic therapy: a review of the literature and possible mechanisms.// J Forensic Sci 1997;42:335-339Swanson JR, Jones GR, Krasselt W et al. Death of two subjects due to imipramine and desipramine metabolite accumulation during chronic therapy: a review of the literature and possible mechanisms.// J Forensic Sci 1997;42:335-339Haverkamp W, Breithardt G, Camm AJ et al. The potential for QT prolongation and proarrhythmia by non-an-tiarrhythmic drugs: clinical and regulatory implications. Report on a policy conference of the European Society of Cardiology // Eur Heart J 2000;21(5):1216-1231Haverkamp W, Breithardt G, Camm AJ et al. The potential for QT prolongation and proarrhythmia by non-an-tiarrhythmic drugs: clinical and regulatory implications. Report on a policy conference of the European Society of Cardiology // Eur Heart J 2000;21(5):1216-1231Ogata N, Narahashi T. Block of sodium channels by psychotropic drugs in single quinea-pig cardiac myocytes // Br J Pharmacol 1989;97(3):905-913Ogata N, Narahashi T. Block of sodium channels by psychotropic drugs in single quinea-pig cardiac myocytes // Br J Pharmacol 1989;97(3):905-913Crumb WJ, Beasley C, Thornton A et al. Cardiac ion channel blocking profile of olanzapine and other antipsychotics. Presented at the 38th American College of Neuropsychopharmacology Annual Meeting; Acapulco, Mexico; December 12-16,1999Crumb WJ, Beasley C, Thornton A et al. Cardiac ion channel blocking profile of olanzapine and other antipsychotics. Presented at the 38th American College of Neuropsychopharmacology Annual Meeting; Acapulco, Mexico; December 12-16,1999Jo SH, Youm JB, Lee CO et al. Blocade of the HERG human cardiac K+channel by the antidepressant drug amitriptyline.// Br J Pharmacol 2000;129:1474-1480Jo SH, Youm JB, Lee CO et al. Blocade of the HERG human cardiac K+channel by the antidepressant drug amitriptyline.// Br J Pharmacol 2000;129:1474-1480Kupriyanov VV, Xiang B, Yang L, Deslauriers R. Lithium ion as a probe of Na+channel activity in isolated rat hearts: a multinuclear NMR study.// NMR Biomed 1997;10:271-276Kupriyanov VV, Xiang B, Yang L, Deslauriers R. Lithium ion as a probe of Na+channel activity in isolated rat hearts: a multinuclear NMR study.// NMR Biomed 1997;10:271-276Kiesecker C, Alter M, Kathofer S et al. Atypical tetracyclic antidepressant maprotiline is an antagonist at cardiac HERG potassium channels.// Naunyn Schmiedebergs Arch Pharmacol 2006;373(3):212-220Kiesecker C, Alter M, Kathofer S et al. Atypical tetracyclic antidepressant maprotiline is an antagonist at cardiac HERG potassium channels.// Naunyn Schmiedebergs Arch Pharmacol 2006;373(3):212-220Tarantino P, Appleton N, Lansdell K. Effect of trazodone on HERGchannel current and QT-interval.// Eur J Pharmacol 2005;510(1-2):75-85Tarantino P, Appleton N, Lansdell K. Effect of trazodone on HERGchannel current and QT-interval.// Eur J Pharmacol 2005;510(1-2):75-85Jow F, Tseng E, Maddox T et al. Rb+ efflux through functional activation of cardiac KCNQ1/mink channels by the benzodiazepine R-L3 (L-364,373).// Assay Drug Dev Technol 2006;4(4):443-450Jow F, Tseng E, Maddox T et al. Rb+ efflux through functional activation of cardiac KCNQ1/mink channels by the benzodiazepine R-L3 (L-364,373).// Assay Drug Dev Technol 2006;4(4):443-450Rajamani S, Eckhardt LL, Valdivia CR et al. Drug-induced long QT syndrome: HERG K+ channel block and disruption of protein trafficking by fluoxetine and nor-fluoxetine.// Br J Pharmacol 2006;149(5):481-489Rajamani S, Eckhardt LL, Valdivia CR et al. Drug-induced long QT syndrome: HERG K+ channel block and disruption of protein trafficking by fluoxetine and nor-fluoxetine.// Br J Pharmacol 2006;149(5):481-489Glassman AH. Schizophrenia, antipsychotic drugs, and cardiovascular disease.// J Clin Psychiatry 2005;66 Suppl 6:5-10Glassman AH. Schizophrenia, antipsychotic drugs, and cardiovascular disease.// J Clin Psychiatry 2005;66 Suppl 6:5-10Shamgar L, Ma L, Schmitt N et al. Calmodulin is essential for cardiac IKS channel gating and assembly: impaired function in long-QT mutations.// Circ Res 2006;98(8):1055-1063Shamgar L, Ma L, Schmitt N et al. Calmodulin is essential for cardiac IKS channel gating and assembly: impaired function in long-QT mutations.// Circ Res 2006;98(8):1055-1063Hull BE, Lockwood TD. Toxic cardiomyopaty: the effect of antipsychotic-antidepressant drugs and calcium on myocardial protein degradation and structural integrity.// Toxicol Appl Pharmacol 1986;86(2):308-324Hull BE, Lockwood TD. Toxic cardiomyopaty: the effect of antipsychotic-antidepressant drugs and calcium on myocardial protein degradation and structural integrity.// Toxicol Appl Pharmacol 1986;86(2):308-324Reilly JG, Ayis SA, Ferrier IN et al. QTc-interval abnormalties and psychotropic drugs therapy in psychiatric patients.// Lancet 2000;355(9209):1048-1052Reilly JG, Ayis SA, Ferrier IN et al. QTc-interval abnormalties and psychotropic drugs therapy in psychiatric patients.// Lancet 2000;355(9209):1048-1052Andreassen OA, Steen VM. [Pharmacogenetics and tailored drug treatment in schizophrenia].// Tidsskr Nor Laegeforen 2006;126(18):2400-2402Andreassen OA, Steen VM. [Pharmacogenetics and tailored drug treatment in schizophrenia].// Tidsskr Nor Laegeforen 2006;126(18):2400-2402Kutscher EC, Carnahan R. Common CYP450 interactions with psychiatric medicines: A brief review for the primary care physician.//S D Med 2006;59(1):5-9Kutscher EC, Carnahan R. Common CYP450 interactions with psychiatric medicines: A brief review for the primary care physician.//S D Med 2006;59(1):5-9Kropp S, Lichtinghagen R, Winterstein K et al. Cytochrome P450 2D6 and 2C19 polymorphisms and length of hospitalization in psychiatry.// Clin Lab 2006;52(5-6):237-240Kropp S, Lichtinghagen R, Winterstein K et al. Cytochrome P450 2D6 and 2C19 polymorphisms and length of hospitalization in psychiatry.// Clin Lab 2006;52(5-6):237-240Daniel WA. The influence of long-term treatment with psychotropic drugs on cytochrome P450: the involvement of different mechanisms.// Expert Opin Drug Metab Toxicol 2005;1(2):203-217Daniel WA. The influence of long-term treatment with psychotropic drugs on cytochrome P450: the involvement of different mechanisms.// Expert Opin Drug Metab Toxicol 2005;1(2):203-217Kootstra-Ros JE, Van Weelden MJ, Hinrichs JM et al. Therapeutic drug monitoring of antidepressants and cytochrome P450 genotyping in general practice.// J Clin Pharmacol 2006;46(11):1320-1327Kootstra-Ros JE, Van Weelden MJ, Hinrichs JM et al. Therapeutic drug monitoring of antidepressants and cytochrome P450 genotyping in general practice.// J Clin Pharmacol 2006;46(11):1320-1327Андреев Б.В., Лиманкина И.Н. Проблема интервала QT в психиатрической практике.// Медицина ХХ век 2006;4:41-44Андреев Б.В., Лиманкина И.Н. Проблема интервала QT в психиатрической практике.// Медицина ХХ век 2006;4:41-44

The authors declare that there are no conflicts of interest present.